NRG/HER Restoration of the Lung Epithelium After Injury
NRG/HER Restoration of the Lung Epithelium After Injury
批准号:
7255627
负责人:
JEFFREY A KERN
金额:
$36.62万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-09-01 至 2009-06-30
关键词:
Acute Lung InjuryAddressAffectAffinityAnimalsApoptosisAppendixBackBiochemicalBleomycinCollagenComplexDataDefectDependenceDepositionDominant Negative ReceptorDominant-Negative MutationERBB2 geneERBB3 geneEnd PointEpidermal Growth FactorEpidermal Growth Factor ReceptorEpithelial Cell ProliferationEpithelial CellsEpitheliumEventFaceFamilyFamily memberFeedbackFetal LungFibrosisGoalsGrowthGrowth FactorGrowth Factor ReceptorsGrowth and Development functionHER2 inhibitionHumanIn VitroInflammationInflammatoryInflammatory ResponseInjuryKnowledgeLaboratoriesLigandsLocalizedLungManuscriptsMechanicsMediatingMembraneModelingMouse StrainsNeuregulin 1NeuregulinsPathway interactionsPatientsPhenotypePhosphorylationPlayPrincipal InvestigatorProcessProductionProtein CReceptor ActivationReceptor Protein-Tyrosine KinasesReceptor SignalingRecoveryRegulationRoleSTAT3 geneSignal TransductionSystemTestingTransactivationTransgenic MiceTransgenic OrganismsTyrosine PhosphorylationWorkcell growthcell injurycytokinefeedingin vitro Modelin vivoinhibitor/antagonistinsightloss of functionlung injurymembernovel therapeuticspreventprogramspromoterreceptorreceptor bindingrepairedresponserestorationsurfactant
中文摘要
描述(由申请人提供):急性肺损伤及其对肺上皮的损害和由此导致的纤维化在美国每年影响约20/100,000。肺上皮细胞、生长因子及其同源受体在这种恢复中起着积极的作用。然而,目前还不清楚哪些生长因子和受体参与其中,以及它们指导了哪些过程。我的实验室已经在肺中发现了一个膜结合的受体酪氨酸激酶家族,即人表皮生长因子样受体家族(HER2、3和4),其表达定位于肺上皮细胞。我们对HER系统及其配体神经调节蛋白-1(NRG-1)的研究表明,它们在肺上皮细胞损伤后的恢复中发挥着重要作用。这一认识使我们假设:在肺损伤过程中或之后,肺上皮细胞中HER2/HER3受体的激活通过促纤维化细胞因子的形成而引导纤维化反应,并促进上皮细胞修复。这项建议的目的是在体内使用NRG-1/HER2/HER3轴上存在肺特异性缺陷的转基因小鼠来验证这一假说,并在体外确定受体激活和下游信号转导的机制。在这一应用中,我们建议:1)使用具有显性负HERS受体的独特转基因小鼠品系,确定HER2/HER3受体复合体在调节纤维化细胞因子级联反应中的作用;2)确定HER2/HER3受体在损伤过程中激活导致纤维化细胞因子产生的机制;以及3)使用显性负STAT3分子来了解HER2/HER3诱导的STAT3的激活及其在上皮修复中的作用。将使用博莱霉素和机械损伤模型在体内和体外启动肺损伤,并确定HER2/HER3受体的激活和失活对上皮细胞引导纤维化、炎症、增殖和凋亡能力的影响(S)。对肺修复过程中重要的生长因子、受体和诱导信号的识别将为确定纤维化或其他肺损伤患者的新治疗策略奠定基础。
英文摘要
DESCRIPTION (provided by applicant): Acute lung injury with its associated damage to the pulmonary epithelium and the resultant fibrosis affects approximately 20/100,000 /year in the US. Pulmonary epithelial cells, growth factors and their cognate receptors play an active role in this recovery. However, which growth factors and receptors participate and what processes they direct remains unclear. My laboratory has identified a membrane bound receptor tyrosine kinase family in the lung, the human epidermal growth factor-like receptor family (HER2, 3 and 4), whose expression is localized to the pulmonary epithelium. Our studies of the HER system and its ligand, Neuregulin-1 (NRG-1), suggest they play an important role in the recovery of pulmonary epithelial cells from injury. This knowledge has led us to hypothesize that: Activation of the HER2/HER3 receptor in pulmonary epithelial cells during or after lung injury directs a fibrotic response via the elaboration of pro-fibrotic cytokine cascades and promotes epithelial cell repair. The goal of this proposal is to test this hypothesis in vivo using transgenic mice with lung specific defects in the NRG-1/HER2/HER3 axis and define mechanisms of receptor activation and downstream signaling in vitro. In this application we propose to: 1) Define the HER2/HER3 receptor complex's role in the regulation of fibrotic cytokine cascades using unique transgenic mouse strains with lung specific expression of a dominant negative HERS receptor, 2) Define mechanisms of HER2/HER3 receptor activation during injury that results in fibrotic cytokine production, and 3) Use a dominant negative STAT3 molecule to understand the HER2/HER3 induced activation of STAT3, and its role in repair of the epithelium. Bleomycin and mechanical injury models will be used in vivo and in vitro to initiate lung injury and determine the effect(s) of HER2/HER3 receptor activation and inactivation on the epithelium's ability to direct fibrosis, inflammation, proliferation, and apoptosis. The identification of growth factors, receptors, and induced signals important in the pulmonary repair process will lay the groundwork for identification of new therapeutic strategies for patients with fibrotic or otherwise damaged lungs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Identification of pathways to mitigate Immune-Related Adverse Events with Cancer Immunotherapy
-
批准号:10395923
-
项目类别:
-
资助金额:$61.09万
-
财政年份:2020
-
负责人:JEFFREY A KERN
-
依托单位:
Identification of pathways to mitigate Immune-Related Adverse Events with Cancer Immunotherapy
-
批准号:10593951
-
项目类别:
-
资助金额:$61.38万
-
财政年份:2020
-
负责人:JEFFREY A KERN
-
依托单位:
Identification of pathways to mitigate Immune-Related Adverse Events with Cancer Immunotherapy
-
批准号:9920595
-
项目类别:
-
资助金额:$63.86万
-
财政年份:2020
-
负责人:JEFFREY A KERN
-
依托单位:
NRG/HER Restoration of the Lung Epithelium After Injury
-
批准号:6979291
-
项目类别:
-
资助金额:$35.9万
-
财政年份:2005
-
负责人:JEFFREY A KERN
-
依托单位:
NRG/HER Restoration of the Lung Epithelium After Injury
-
批准号:7459815
-
项目类别:
-
资助金额:$36.62万
-
财政年份:2005
-
负责人:JEFFREY A KERN
-
依托单位:
NRG/HER Restoration of the Lung Epithelium After Injury
-
批准号:7116266
-
项目类别:
-
资助金额:$37.72万
-
财政年份:2005
-
负责人:JEFFREY A KERN
-
依托单位:
HER RECEPTOR FAMILY, HEREGULIN AND LUNG DEVELOPMENT
-
批准号:6476863
-
项目类别:
-
资助金额:$27.49万
-
财政年份:2000
-
负责人:JEFFREY A KERN
-
依托单位:
HER RECEPTOR FAMILY, HEREGULIN AND LUNG DEVELOPMENT
-
批准号:6330165
-
项目类别:
-
资助金额:$27.4万
-
财政年份:2000
-
负责人:JEFFREY A KERN
-
依托单位:
HER RECEPTOR FAMILY, HEREGULIN AND LUNG DEVELOPMENT
-
批准号:2758559
-
项目类别:
-
资助金额:$23.63万
-
财政年份:1998
-
负责人:JEFFREY A KERN
-
依托单位:
HER RECEPTOR FAMILY, HEREGULIN AND LUNG DEVELOPMENT
-
批准号:6125878
-
项目类别:
-
资助金额:$26.1万
-
财政年份:1998
-
负责人:JEFFREY A KERN
-
依托单位:
PHYSICIAN SCIENTIST AWARD
-
批准号:3087269
-
项目类别:
-
资助金额:$7.56万
-
财政年份:1988
-
负责人:JEFFREY A KERN
-
依托单位:
PHYSICIAN SCIENTIST AWARD
-
批准号:3087270
-
项目类别:
-
资助金额:$7.56万
-
财政年份:1988
-
负责人:JEFFREY A KERN
-
依托单位:
PHYSICIAN SCIENTIST AWARD
-
批准号:3087268
-
项目类别:
-
资助金额:$7.56万
-
财政年份:1988
-
负责人:JEFFREY A KERN
-
依托单位:
PHYSICIAN SCIENTIST AWARD
-
批准号:3087267
-
项目类别:
-
资助金额:$8.18万
-
财政年份:1986
-
负责人:JEFFREY A KERN
-
依托单位:
PHYSICIAN SCIENTIST AWARD
-
批准号:3087266
-
项目类别:
-
资助金额:$8.27万
-
财政年份:1986
-
负责人:JEFFREY A KERN
-
依托单位:
POSTTRANSCRIPTIONAL REGULATION, PROCESSING, AND SECRETION OF INTERLEUKIN 1
-
批准号:5213625
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:JEFFREY A KERN
-
依托单位:--
海外基金